Gene · 6007
Papers4,511
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
761 to 780 of 4,511
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Detection of ABO Discrepancy in a Case of Coronary Artery Disease by Conventional Tube Technique: A Miss by Column Agglutination Technology. | J Lab Physicians | 2022 | 36186255 | PubTator, text mining | PubMed |
| Estimating the effect of donor sex on red blood cell transfused patient mortality: A retrospective cohort study using a targeted learning and emulated trials-based approach. | EClinicalMedicine | 2022 | 36176312 | PubTator, text mining | PubMed |
| Altered Fc glycosylation of anti-HLA alloantibodies in hemato-oncological patients receiving platelet transfusions. | J Thromb Haemost | 2022 | 36165642 | PubTator, text mining | PubMed |
| Safety of Uncrossmatched ABO-Compatible RBCs in Alloimmunized Patients with Bleeding: Data from Two Decades: Results of a Systematic Analysis in 6,109 Patients. | Transfus Med Hemother | 2022 | 36159957 | PubTator, text mining | PubMed |
| Robust possibilistic programming to design a closed-loop blood supply chain network considering service-level maximization and lateral resupply. | Ann Oper Res | 2022 | 36157977 | PubTator, text mining | PubMed |
| When should RhD-negative recipients be spared the transfusion of DEL red cells to avoid anti-D alloimmunization? | Transfusion | 2022 | 36156264 | PubTator, text mining | PubMed |
| Novel pyroptosis-associated genes signature for predicting the prognosis of sarcoma and validation. | Biosci Rep | 2022 | 36155774 | PubTator, text mining | PubMed |
| Nuclear Factor Kappa B Promotes Ferritin Heavy Chain Expression in Bombyx mori in Response to B. mori Nucleopolyhedrovirus Infection. | Int J Mol Sci | 2022 | 36142290 | PubTator, text mining | PubMed |
| Essential laboratory tests for medical education. | Acad Pathol | 2022 | 36133797 | PubTator, text mining | PubMed |
| [Prenatal care in Germany: which medical examinations are officially recommended in the guidelines]. | MMW Fortschr Med | 2022 | 36123485 | PubTator, text mining | PubMed |
| International Society of Blood Transfusion Working Party on Red Cell Immunogenetics and Blood Group Terminology Report of Basel and three virtual business meetings: Update on blood group systems. | Vox Sang | 2022 | 36121188 | PubTator, text mining | PubMed |
| Selected ginsenosides interfere efficiently with hepatitis B virus mRNA expression levels and suppress viral surface antigen secretion. | Heliyon | 2022 | 36110238 | PubTator, text mining | PubMed |
| Use of O RhD-negative red blood cells: A nationwide, prospective audit. | Vox Sang | 2022 | 36102215 | PubTator, text mining | PubMed |
| Modelling the outcomes of different red blood cell transfusion strategies for the treatment of traumatic haemorrhage in the prehospital setting in the United Kingdom. | Vox Sang | 2022 | 36102164 | PubTator, text mining | PubMed |
| Whole blood transfusion and paroxysmal nocturnal haemoglobinuria meet again: Minor incompatibility, major trouble. | Vox Sang | 2022 | 36102159 | PubTator, text mining | PubMed |
| Laser incubation for the rapid detection of red cell alloantibodies in human blood samples. | Vox Sang | 2022 | 36102143 | PubTator, text mining | PubMed |
| Single-exon approach to non-invasive fetal RHD screening in early pregnancy: An update after 10 years' experience. | Vox Sang | 2022 | 36102142 | PubTator, text mining | PubMed |
| HLA Class II regulation of immune response in sickle cell disease patients: Susceptibility to red blood cell alloimmunization (systematic review and meta-analysis). | Vox Sang | 2022 | 36102140 | PubTator, text mining | PubMed |
| Strategies to inhibit FGFR4 V550L-driven rhabdomyosarcoma. | Br J Cancer | 2022 | 36097178 | PubTator, text mining | PubMed |
| Severe neonatal hyperbilirubinemia secondary to combined RhC hemolytic disease, congenital hypothyroidism and large adrenal hematoma: a case report. | BMC Pediatr | 2022 | 36089589 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6007/papers?page=39